BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 25149081)

  • 1. Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis.
    Mizee MR; Nijland PG; van der Pol SM; Drexhage JA; van Het Hof B; Mebius R; van der Valk P; van Horssen J; Reijerkerk A; de Vries HE
    Acta Neuropathol; 2014 Nov; 128(5):691-703. PubMed ID: 25149081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
    van Doorn R; Nijland PG; Dekker N; Witte ME; Lopes-Pinheiro MA; van het Hof B; Kooij G; Reijerkerk A; Dijkstra C; van van der Valk P; van Horssen J; de Vries HE
    Acta Neuropathol; 2012 Sep; 124(3):397-410. PubMed ID: 22810490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood-brain barrier in cortical multiple sclerosis lesions.
    van Horssen J; Brink BP; de Vries HE; van der Valk P; Bø L
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):321-8. PubMed ID: 17413323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles for HB-EGF and CD9 in multiple sclerosis.
    Schenk GJ; Dijkstra S; van het Hof AJ; van der Pol SM; Drexhage JA; van der Valk P; Reijerkerk A; van Horssen J; de Vries HE
    Glia; 2013 Nov; 61(11):1890-905. PubMed ID: 24038577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions.
    van Horssen J; Drexhage JA; Flor T; Gerritsen W; van der Valk P; de Vries HE
    Free Radic Biol Med; 2010 Nov; 49(8):1283-9. PubMed ID: 20673799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytes as a regulated source of retinoic acid for the brain.
    Shearer KD; Fragoso YD; Clagett-Dame M; McCaffery PJ
    Glia; 2012 Dec; 60(12):1964-76. PubMed ID: 22930583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
    Nijland PG; Witte ME; van het Hof B; van der Pol S; Bauer J; Lassmann H; van der Valk P; de Vries HE; van Horssen J
    Acta Neuropathol Commun; 2014 Dec; 2():170. PubMed ID: 25492529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of monomethyl fumarate at the inflamed blood-brain barrier.
    Lim JL; van der Pol SM; Di Dio F; van Het Hof B; Kooij G; de Vries HE; van Horssen J
    Microvasc Res; 2016 May; 105():61-9. PubMed ID: 26679389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM-CSF promotes migration of human monocytes across the blood brain barrier.
    Vogel DY; Kooij G; Heijnen PD; Breur M; Peferoen LA; van der Valk P; de Vries HE; Amor S; Dijkstra CD
    Eur J Immunol; 2015 Jun; 45(6):1808-19. PubMed ID: 25756873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.
    Chapouly C; Tadesse Argaw A; Horng S; Castro K; Zhang J; Asp L; Loo H; Laitman BM; Mariani JN; Straus Farber R; Zaslavsky E; Nudelman G; Raine CS; John GR
    Brain; 2015 Jun; 138(Pt 6):1548-67. PubMed ID: 25805644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.
    Draheim T; Liessem A; Scheld M; Wilms F; Weißflog M; Denecke B; Kensler TW; Zendedel A; Beyer C; Kipp M; Wruck CJ; Fragoulis A; Clarner T
    Glia; 2016 Dec; 64(12):2219-2230. PubMed ID: 27641725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans.
    Mora P; Hollier PL; Guimbal S; Abelanet A; Diop A; Cornuault L; Couffinhal T; Horng S; Gadeau AP; Renault MA; Chapouly C
    PLoS Biol; 2020 Nov; 18(11):e3000946. PubMed ID: 33253145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional culture conditions differentially affect astrocyte modulation of brain endothelial barrier function in response to transforming growth factor β1.
    Hawkins BT; Grego S; Sellgren KL
    Brain Res; 2015 May; 1608():167-76. PubMed ID: 25721792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation and astrocytic reaction in the course of Phoneutria nigriventer (armed-spider) blood-brain barrier (BBB) opening.
    da Cruz-Höfling MA; Rapôso C; Verinaud L; Zago GM
    Neurotoxicology; 2009 Jul; 30(4):636-46. PubMed ID: 19393263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.
    Saikali P; Antel JP; Pittet CL; Newcombe J; Arbour N
    J Immunol; 2010 Nov; 185(10):5693-703. PubMed ID: 20926794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cypermethrin induces astrocyte damage: role of aberrant Ca(2+), ROS, JNK, P38, matrix metalloproteinase 2 and migration related reelin protein.
    Maurya SK; Mishra J; Tripathi VK; Sharma R; Siddiqui MH
    Pestic Biochem Physiol; 2014 May; 111():51-9. PubMed ID: 24861934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis.
    Kooij G; Mizee MR; van Horssen J; Reijerkerk A; Witte ME; Drexhage JA; van der Pol SM; van Het Hof B; Scheffer G; Scheper R; Dijkstra CD; van der Valk P; de Vries HE
    Brain; 2011 Feb; 134(Pt 2):555-70. PubMed ID: 21183485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions.
    Alvarez JI; Saint-Laurent O; Godschalk A; Terouz S; Briels C; Larouche S; Bourbonnière L; Larochelle C; Prat A
    Neurobiol Dis; 2015 Feb; 74():14-24. PubMed ID: 25448765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.
    Haarmann A; Nowak E; Deiß A; van der Pol S; Monoranu CM; Kooij G; Müller N; van der Valk P; Stoll G; de Vries HE; Berberich-Siebelt F; Buttmann M
    Acta Neuropathol; 2015 May; 129(5):639-52. PubMed ID: 25814153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
    Nijland PG; Michailidou I; Witte ME; Mizee MR; van der Pol SM; van Het Hof B; Reijerkerk A; Pellerin L; van der Valk P; de Vries HE; van Horssen J
    Glia; 2014 Jul; 62(7):1125-41. PubMed ID: 24692237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.